AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H951. A total of 4 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,954,786 | -14.6% | 980,600 | +0.7% | 0.01% | -14.3% |
| Q2 2023 | $21,013,494 | +9.1% | 974,200 | +48.5% | 0.01% | -12.5% |
| Q1 2023 | $19,252,908 | -16.3% | 656,200 | +5.4% | 0.01% | -27.3% |
| Q4 2022 | $22,993,985 | +167.9% | 622,300 | +104.1% | 0.01% | +175.0% |
| Q3 2022 | $8,583,000 | +3360.9% | 304,900 | +2263.6% | 0.00% | – |
| Q2 2022 | $248,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 133,300 | $2,440,723 | 0.01% |
| JANE STREET GROUP, LLC | 980,600 | $17,954,786 | 0.01% |
| Worth Venture Partners, LLC | 22,300 | $9,478 | 0.01% |
| SIMPLEX TRADING, LLC | 117,500 | $2,151 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |